RecruitingNot ApplicableNCT06138249
Cholecalciferol and Calcifediol Are Both Useful to Improve Vitamin D Serum Levels
Different Kinds of Vitamin D Intake and Its Metabolites: Blood Levels and Bone Mineral Density. A Randomized Clinical Trial.
Sponsor
Azienda Ospedaliero-Universitaria Consorziale Policlinico di Bari
Enrollment
90 participants
Start Date
Jul 1, 2023
Study Type
INTERVENTIONAL
Conditions
Summary
Patients with hypovitaminosis D are randomized into three arms of treatment: Group A: Calcifediol 0,266mg each month Group B: Cholecalciferol 25000UI each 15 days Group C: Calcifediol 4 drops per day. Serum levels of vitamin D are dosed after one month of treatment
Eligibility
Min Age: 18 YearsMax Age: 80 Years
Inclusion Criteria1
- Hypovitaminosis D (\<20ng/mL)
Exclusion Criteria2
- Osteoporosis (T score \<-2.5SD)
- Renal or hepatic diseases
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
DIETARY_SUPPLEMENTVitamin D
Vitamin D
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06138249
Related Trials
Evaluating Response to Vitamin D3 and K2 Supplementation in Healthcare Personnel
NCT071998291 location
Bone Outcomes, Obesity, Sunlight, and Trauma in Children
NCT071435522 locations
Effect of Vitamin D3 Supplementation on Brain Waves in Male Epileptic Patients With Hypovitaminosis D
NCT070964141 location
Replenishment of Vitamin D in Hip fractured Patients (REVITAHIP) Trial
ACTRN126100003920661 location